Open AccessExperience with the carbamylated monomeric allergoid Lais® for sublingual immunotherapy in patients with grass pollen or mite-induced allergic rhinoconjunctivitis
Author(s) -
И В Данилычева,
N I Ilina,
A E Shulzhenko
Publication year - 2015
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja497
Subject(s) - sublingual immunotherapy , slit , medicine , mite , desensitization (medicine) , pollen , house dust mite , sublingual administration , immunology , immunotherapy , allergy , dermatology , allergen , immune system , pharmacology , botany , receptor , biology , genetics
The article presents the results of a prospective noncomparative study of carbamylated monomeric allergoid Lais® for sublingual immunotherapy (SLIT) in patients with allergic rhinoconjunctivitis caused by pollen grasses. We suggest that SLIT using Lais® sublingual tablets is an effective and well-tolerated method of treatment.